| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_9259cfa966fe620251340a003f5d6125 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-505
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-73
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-76 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-36 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-395 |
| filingDate |
2006-01-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0528adefe531693e207cb83e893addfd
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_cbc7549e29b22867287453f9dd45b5ba |
| publicationDate |
2006-06-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-2006115471-A1 |
| titleOfInvention |
Treatment of disease with antibodies against high molecular weight kininogen domain 5 |
| abstract |
Antibodies directed against an antigenic determinant of high molecular weight kininogen domain 5, particularly a determinant located in the region formed by light chain amino acids Gly(440) to Lys(502), inhibit angiogenesis. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11372002-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11156612-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-20150106006-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8883153-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-102203880-B1 |
| priorityDate |
1999-11-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |